A Susceptible Mouse Model for Zika Virus Infection

Stuart Dowall, Victoria Graham, Emma Rayner, +7

PLoS neglected tropical diseases

VaccinationVector-borne PathogenClinical SymptomsAllergyNeurovirology +13

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Kathryn A. Ryan, Kevin R. Bewley, Susan Fotheringham, +52

Nature Communications

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

Francisco J. Salguero, Andrew White, Gillian S. Slack, +60

Nature Communications

Virus EpidemiologyViral DiagnosticsViral PathogenesisImmunologyCynomolgus Macaques +15

Functional Domains of the SYT and SYT-SSX Synovial Sarcoma Translocation Proteins and Co-Localization with the SNF Protein BRM in the Nucleus

Claudia Thaete, Dan J. L. Brett, Padraic Monaghan, +5

Human Molecular Genetics

Transcriptional RegulationFunctional DomainsSignal TransductionProtein FunctionProtein Expression +13

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model

Karen R. Buttigieg, Stuart Dowall, Stephen Findlay‐Wilson, +4

PLoS ONE

Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations

S. Sharpe, Andrew White, Charlotte Sarfas, +10

Tuberculosis

Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model

Stuart Dowall, Andrew Bosworth, Robert J. Watson, +9

Journal of General Virology

A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease

Stephen Findlay‐Wilson, Emma Rayner, Geoff Pearson, +1

Human Vaccines & Immunotherapeutics

VaccinationVaccine SafetyCrimean-congo Hemorrhagic FeverVaccine DevelopmentAllergy +13

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

Pamela C. Proud, Daphne Tsitoura, Robert J. Watson, +23

EBioMedicine

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

Pramila Rijal, Sean C. Elias, Samara Rosendo Machado, +25

Cell Reports

VaccinationMucosal VaccinationVaccine DevelopmentAllergyTherapeutic Monoclonal Antibodies +11